Executive Summary
The August 16, 2026, filings reveal a market with strong but uneven growth, characterized by operational leverage in some sectors and margin pressures in others.
Sequent Scientific and WSFX Global Pay posted stellar profit growth (PAT +115% YoY and +84% YoY, respectively), driven by operational efficiencies and favorable segment mix, while Rishabh Instruments saw flat PAT despite revenue growth due to margin compression. A significant capital allocation theme emerges with two companies (ICODEX and Pakka) seeking shareholder approval to deviate from or modify the use of IPO/preferential issue proceeds, raising governance red flags. The infrastructure theme remains robust, with Cube Highways Trust raising its FY27 DPU guidance on the back of strong traffic growth. The M&A landscape is active, with Apollo Micro Systems advancing its open offer for Premier Explosives and Digjam Ltd moving forward with a demerger scheme. Insider activity is notably absent from the filings, but forward-looking statements from Sequent Scientific and Cube Highways provide clear catalysts. The overall sentiment is cautiously optimistic, with a clear divergence between well-managed, high-growth companies and those facing operational or governance challenges.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Corporate governance · M&A · Insolvency
Tracking the trend? Catch up on the prior India Stock Market Daily Regulatory Digest digest from August 15, 2026.
Investment Signals (9)
- Sequent Scientific ↓ (BULLISH)▲
Revenue grew 20% YoY, but PAT surged 115% YoY to ₹79 Cr, driven by a 220 bps gross margin expansion to 54.1% and a 39% reduction in finance costs. This demonstrates powerful operating leverage.
- WSFX Global Pay ↓ (BULLISH)▲
PAT surged 83.82% YoY to ₹0.301 Cr on a 27.57% revenue increase, showing strong operating leverage. The student segment, up 46.83% YoY, is a key growth driver.
- Cube Highways Trust ↓ (BULLISH)▲
Raised FY27 DPU guidance to ₹14.50/unit from ₹14.00/unit, backed by 9.3% YoY traffic growth and 11.5% YoY toll revenue growth. This signals management confidence in cash flow generation.
-
Standalone PAT surged 60% YoY to ₹403.63 Lakh despite a 2.8% revenue decline, driven by a 36.5% YoY jump in other income. The core business is under pressure, but profitability is being propped up by non-operating items. [NEUTRAL/BULLISH]
- Rishabh Instruments ↓ (MIXED)▲
The EEI segment is a standout, with 34% YoY revenue growth and 24.8% EBITDA margins, but the HPDC segment's 41.2% YoY revenue decline is a major drag on overall performance.
- Apollo Micro Systems ↓ (BULLISH)▲
The SEBI clearance for its open offer to acquire 26% of Premier Explosives is a significant step towards consolidation in the defense sector. The offer price and terms will be a key catalyst for PEL shareholders.
- Embassy Developments ↓ (NEUTRAL)▲
The AGM agenda includes a preferential issue of warrants, a potential signal of future capital raising and dilution. The revision of CFO remuneration and appointment of a new Chief Business Officer (Neel Virwani) suggests a strategic management reshuffle.
- Bijoy Hans Ltd (Arvaya Healthcare) ↓ (BULLISH)▲
All six resolutions, including the acquisition of Sushodha Institute, passed with 100% shareholder approval, indicating strong promoter and public support for the company's strategic pivot.
- IFGL Refractories ↓ (NEUTRAL)▲
The promotion of two long-tenured executives (28+ and 37+ years) as Co-Presidents of its key US subsidiary signals a focus on operational continuity and stability.
Risk Flags (8)
- ICODEX PUBLISHING SOLUTIONS↓ [HIGH RISK]▼
Shareholders approved a variation in the use of IPO proceeds and ratified a deviation in their utilization. This is a major red flag, suggesting the original business plan is not working and funds may have been misallocated.
- Sequent Scientific↓ [MEDIUM RISK]▼
EU region revenue in EUR terms was flat YoY at €16.8M due to phasing, and API revenue was flat QoQ due to raw material price volatility. This exposes the company to geographic and input cost concentration risks.
- Rishabh Instruments↓ [HIGH RISK]▼
Consolidated PAT margin declined 50 bps YoY to 9.8%, and gross margin declined 140 bps YoY to 62.4%. The HPDC segment's continued operating losses are a significant drag on profitability.
- Natural Capsules↓ [HIGH RISK]▼
Consolidated net loss of ₹574.38 Lakh persists, only slightly improved from ₹558.05 Lakh loss last year. The standalone business is profitable, but the consolidated entity is bleeding cash, indicating issues with subsidiaries.
- WSFX Global Pay↓ [MEDIUM RISK]▼
Retail segment declined 13.02% YoY, and the company cited cyclical headwinds from geopolitical volatility, FX swings, and US visa policy uncertainty. This makes the business model vulnerable to external macro factors.
- Cube Highways Trust↓ [MEDIUM RISK]▼
One asset (WUPTPL) reached concession end and was handed over to NHAI, reducing the portfolio from 28 to 27 assets. This is a reminder of the finite-life nature of toll road assets and the need for continuous portfolio replenishment.
- Pakka Limited↓ [LOW RISK]▼
Of the total ₹114.62 Cr raised via preferential issue, ₹63.52 Cr from warrants remains outstanding. The company's growth plans (Jagriti Project) are contingent on the future receipt of these funds.
- Digjam Ltd↓ [MEDIUM RISK]▼
The NCLT-convened meeting for the Scheme of Arrangement with Reid & Taylor is a complex corporate restructuring. The outcome of e-voting (results by Aug 18) is critical; any dissent could delay or derail the process.
Opportunities (8)
- Sequent Scientific↓ (OPPORTUNITY)◆
The acquisition of Bio For Life in Italy is a strategic move to strengthen the companion animal health portfolio. Post-acquisition, the company is nearly debt-free (net debt/EBITDA 0.1x), providing significant headroom for further value-accretive M&A.
- Cube Highways Trust↓ (OPPORTUNITY)◆
The raised DPU guidance to ₹14.50/unit for FY27, combined with a strong portfolio traffic growth of 9.3% YoY, offers a compelling yield opportunity. The cumulative DPU of ₹38.81 since listing demonstrates a consistent track record of payouts.
- Apollo Micro Systems↓ (OPPORTUNITY)◆
The open offer for Premier Explosives is a clear catalyst. Investors should watch for the offer price, which could provide a near-term arbitrage opportunity if it is at a premium to the current market price.
- WSFX Global Pay↓ (OPPORTUNITY)◆
The 46.83% YoY growth in the student segment is a powerful tailwind, driven by strong demand for overseas education. If the company can stabilize the retail segment, overall growth could accelerate significantly.
- Natural Capsules↓ (OPPORTUNITY)◆
The standalone business is showing strong profit growth (PAT +60% YoY) and a healthy balance sheet. The persistent consolidated loss may be masking a turnaround opportunity if the subsidiary issues are resolved.
- Embassy Developments↓ (OPPORTUNITY)◆
The AGM on Sep 8 will provide clarity on the preferential issue of warrants. If the issue is at a significant discount, it could be a value-creating opportunity for existing shareholders who participate.
- Virat Industries↓ (OPPORTUNITY)◆
The investor call on Aug 21 to discuss a stake acquisition in Brahm Lifestyle Products is a potential catalyst. The details of the acquisition (valuation, strategic rationale) will determine the opportunity.
- Exato Technologies↓ (OPPORTUNITY)◆
The earnings call on Aug 19 is a key event to gauge the company's performance and outlook. The stock could see significant movement based on the Q1FY27 results and management commentary.
Sector Themes (5)
- Operating Leverage Drives Profit Growth◆
Companies like Sequent Scientific (PAT +115% YoY) and WSFX Global Pay (PAT +84% YoY) are demonstrating that revenue growth, when combined with cost control, can lead to exponential profit growth. This is a key theme for investors to focus on. [IMPLICATION: Favor companies with high operating leverage in a growing economy.]
- Governance Red Flags on Fund Utilization◆
Two companies (ICODEX and Pakka) are seeking or have sought shareholder approval to modify the use of IPO/preferential issue proceeds. This pattern raises concerns about the quality of capital allocation and the original business plans presented to investors. [IMPLICATION: Scrutinize companies that deviate from stated fund utilization plans.]
- Infrastructure & Toll Roads Show Resilience◆
Cube Highways Trust's strong traffic growth (9.3% YoY) and raised DPU guidance underscore the robust demand for infrastructure assets in India. This sector continues to offer stable, inflation-linked cash flows. [IMPLICATION: Infrastructure and toll road assets remain a defensive and growth-oriented play.]
- Uneven Performance in Manufacturing◆
While Sequent Scientific (pharma) is thriving, Rishabh Instruments (HPDC segment) and Natural Capsules (consolidated) are struggling. This indicates a K-shaped recovery in the manufacturing sector, with winners and losers based on product mix and end-market exposure. [IMPLICATION: Stock selection within manufacturing is critical; avoid companies with structurally declining segments.]
- M&A and Restructuring Activity Heats Up◆
The market is seeing a flurry of corporate actions, from Apollo Micro's open offer for Premier Explosives to Digjam's demerger and Virat Industries' potential acquisition. This suggests a period of corporate consolidation and strategic realignment. [IMPLICATION: M&A activity can be a powerful catalyst for stock prices; monitor deal terms and regulatory approvals.]
Watch List (8)
-
E-voting results for the Scheme of Arrangement with Reid & Taylor are expected by August 18, 2026. The outcome will determine the next steps for this complex restructuring. [Date: Aug 18, 2026]
-
Q1FY27 earnings call scheduled for August 19, 2026. This is the first opportunity to hear management's commentary on the company's performance and outlook. [Date: Aug 19, 2026]
-
Debt Investor Roadshow on August 19, 2026. While likely routine, any commentary on credit growth, NIMs, or asset quality will be closely watched by the market. [Date: Aug 19, 2026]
-
Investor meetings with Nuvama and ICICI Securities from Aug 19-21. Watch for any color on the pipeline, especially the launch of generic drugs in the US market. [Date: Aug 19-21, 2026]
-
Investor call on August 21, 2026, to discuss the proposed acquisition of a stake in Brahm Lifestyle Products. The valuation and strategic rationale will be key. [Date: Aug 21, 2026]
-
AGM on September 8, 2026, with key resolutions including a preferential issue of warrants and management remuneration. The outcome will signal management's confidence and future capital plans. [Date: Sep 8, 2026]
-
The open offer for Premier Explosives is now proceeding after SEBI comments. The timeline for the public announcement and the offer price will be the next key catalysts. [Date: TBD]
-
The acquisition of Bio For Life in Italy is a key catalyst. Watch for completion timelines and any integration-related updates. The company's near-debt-free balance sheet provides significant M&A firepower. [Date: TBD]
Filing Analyses
(22)
15-08-2026
Pakka Limited filed a statement under Regulation 32 of SEBI LODR confirming no deviation or variation in the utilisation of proceeds from its preferential issue of equity shares and warrants, which raised a total of ₹114.62 Crore during Q1 FY26 (ended June 30, 2026). Of the ₹51.10 Crore received by June 9, 2026 (from total proceeds of ₹114.62 Crore), the entire amount was fully utilised towards the Jagriti Project (capital expenditure and loan repayment), with no unutilised funds as of June 30, 2026. The filing reflects compliance with fund utilisation disclosures, but the balance ₹63.52 Crore from warrants remains outstanding as of the quarter end, pending future receipt.
- · The company raised funds through a preferential issue of 27.20 lakh equity shares to non-promoters at ₹110 per share (including share premium of ₹100 per share).
- · An additional preferential issue of 77 lakh fully convertible warrants (at ₹110 per warrant) was made to promoter category persons, with 25% upfront payment (₹27.50 per warrant) received on allotment, and the remaining 75% (₹82.50 per warrant) to be received within 18 months from allotment.
- · The warrant subscription price is ₹27.50 per warrant (24% upfront) and the warrant exercise price is ₹82.50 per warrant (balance 76%).
- · Total warrants authorised by the EGM: 90,90,000 (90.9 lakh) warrants.
- · Jagriti Project scope includes: new PM-4 (100 TPD capacity), upgrade of PM-3 (70 TPD to 80 TPD), pulp mill capacity increase (135 TPD to 175 TPD), additional 15 MW power plant.
- · Implementation in three phases: phase I (upgradation), phase II (new plant & machinery), phase III (integration, trial and stabilisation).
- · The audit committee reviewed the statement on August 13, 2026, and the board on August 14, 2026.
- · The monitoring agency is Brickwork Ratings India Private Limited.
- · The amount raised from the equity shares portion (₹29.92 Cr) was fully subscribed and received in full.
16-08-2026
Arvaya Healthcare Limited (formerly Bijoy Hans Limited) submitted voting results and the scrutinizer's report for a postal ballot held on August 13, 2026. All six resolutions, including the regularization of an executive director, acquisition of Sushodha Institute of Gastroenterology Private Limited, preferential share issuance, ratification of a revised CA certificate, shifting of registered office from Assam to Maharashtra, and modification of lock-in periods, were passed with 100% votes in favor from both promoters and public shareholders. The company had 3,416 shareholders on record, and total voter turnout ranged from 35.5% to 69.7% across resolutions.
- · All six resolutions received 100% votes in favor from both promoter and public categories, with no votes against or invalid votes.
- · Resolution 2 (acquisition of Sushodha Institute and related party transactions) had the lowest voter turnout at 35.5%, and promoters did not vote on this resolution.
- · Resolutions 1, 4, and 5 had the highest voter turnout at 69.7%.
- · The scrutinizer's report was issued on August 14, 2026, and the board meeting appointing the scrutinizer was held on July 11, 2026.
16-08-2026
Viyash Scientific (formerly Sequent Scientific) reported strong Q1 FY27 results with revenue of ₹946 Cr (+20% YoY), EBITDA of ₹205 Cr (+59% YoY, margin 21.6%), and PAT of ₹79 Cr (+115% YoY). Net debt reduced to ₹86 Cr (net debt/EBITDA 0.1x), making the balance sheet nearly debt-free. However, EU region revenue in EUR terms was flat YoY at €16.8M due to phasing, and API revenue was flat QoQ due to raw material price volatility. The company signed an SPA to acquire Bio For Life in Italy to strengthen companion animal health.
- · Gross margin improved to 54.1% from 51.9% in Q1 FY26, up 220 bps YoY.
- · Finance costs declined to ₹12.5 Cr from ₹20.4 Cr in Q1 FY26.
- · ESOP expense of ₹19 Cr was incurred in Q1 FY27 due to granting of options representing 2.8% of post-amalgamation paid-up capital.
- · The company signed an SPA to acquire BioForLife in Italy, adding ~85 companion animal products and ~85% vet clinic coverage in Italy.
- · US business grew ~45% YoY in dollar terms; emerging markets grew ~23% YoY in dollar terms.
- · Management expects EU revenue to grow 18-20% on a full-year INR basis, and API revenue to rebound in Q2.
- · Company's name changed from Sequent Scientific Limited to Viyash Scientific Limited.
16-08-2026
Cube Highways Trust reported Q1 FY27 results with revenue from operations up 19.31% YoY to INR 11,266 Mn and consolidated income of INR 11,568 Mn. Portfolio traffic grew 9.3% YoY, driving toll revenue growth of 11.5% YoY. The company declared a DPU of INR 3.95 for the quarter and raised FY27 DPU guidance to INR 14.50/unit from INR 14.00/unit. However, one asset (WUPTPL) reached concession end on June 23, 2026, and was handed over to NHAI, reducing the portfolio from 28 to 27 assets. Net debt/AUM stood at 45.17% with an average cost of debt of 7.49%.
- · WUPTPL concession ended on June 23, 2026, and the asset was handed over to NHAI, reducing portfolio from 28 to 27 assets.
- · Q1 FY27 DPU of INR 3.95 declared; cumulative DPU per unit since listing is INR 38.81.
- · FY27 DPU guidance raised to INR 14.50/unit from INR 14.00/unit.
- · Offer for Sale of INR 50,000 Mn was subscribed 9.42x with participation from 12 Mutual Funds, 21 Insurance Companies, 5 Pension Funds.
- · Average cost of debt stands at 7.49%.
- · DSCR (trailing 12 months) is 2.0x.
- · Debt/EBITDA leverage is 4.18x.
- · Net Debt/AUM is 45.17%.
- · AAA credit rating from CRISIL, India Ratings, and ICRA.
- · Annual Pass adoption for private cars is 32% across the portfolio.
- · Annuity receipts for Q1 FY27 fully received.
- · RBI GDP forecast for FY27 is 6.7%; Q1 FY27 GDP growth at 7.0%.
- · Toll revenue growth of 11.5% YoY includes INR 1,081 Mn of Annual Pass compensation.
- · On a comparable 84-day basis (excluding WUPTPL), toll portfolio revenue growth would have been 12.0% YoY.
- · Major maintenance works completed at WUPTPL; ongoing at NAMEPL within schedule and budget.
- · Awards: GAEPL won 'Excellence in Highway Asset Management' at RAHSTA Awards 2026; SMTPL won 'Best Smart Highway / Intelligent Transport Solution'; Build India Infra Awards 2026 for 'Best O&M Practices'.
16-08-2026
Maan Aluminium Limited has filed a statement of deviation or variation in the utilization of funds raised through a preferential issue of equity for the quarter ended June 30, 2026, as required under Regulation 32 of SEBI (LODR) Regulations. The statement was reviewed and approved by the Audit Committee on August 13, 2026. No specific deviation or variation amounts are disclosed in the filing.
- · Filing is a compliance disclosure under Regulation 32 of SEBI LODR for the quarter ended June 30, 2026.
- · The statement was reviewed and approved by the Audit Committee on August 13, 2026.
- · Funds were raised through a preferential issue of equity shares.
- · No specific deviation or variation amounts are provided in the filing text.
16-08-2026
ICODEX PUBLISHING SOLUTIONS LIMITED announced that its shareholders have approved two special resolutions via postal ballot: (1) variation in the objects/terms of utilization of IPO proceeds and modification of the time limit for their utilization, and (2) ratification of deviation in utilization of IPO proceeds. The resolutions were passed with overwhelming support, with 99.811% of votes cast in favor and only 0.189% against, though voter turnout was 74.43% of total outstanding shares. The company is seeking to change how it uses the funds raised from its initial public offering, which may raise concerns about the original use of proceeds.
- · The record date for the postal ballot was July 10, 2026.
- · Total outstanding shares of the company are 15,637,020.
- · Promoter and promoter group hold 10,076,100 shares (64.4% of total).
- · Public non-institutions hold 5,560,920 shares (35.6% of total).
- · No public institutional shareholders participated in the voting.
- · There were zero invalid votes from any category.
- · The scrutinizer's report was issued on August 14, 2026.
16-08-2026
ICODEX PUBLISHING SOLUTIONS LIMITED shareholders passed two special resolutions via postal ballot on August 14, 2026, approving (1) variation in the objects/terms of utilization of IPO proceeds and modification of the time limit for utilization, and (2) ratification of deviation in utilization of IPO proceeds. The resolutions were passed with overwhelming support (99.811% in favor), though public non-institutional shareholders showed a small but notable opposition (1.3457% against). The company is making the voting results and scrutinizer's report available on its website and the e-voting agency's site.
- · Record date for the postal ballot was July 10, 2026.
- · Scrutinizer's report dated August 14, 2026.
- · Promoter and promoter group voted 100% in favor via e-voting.
- · Public institutions did not participate in voting (0 votes polled).
- · Public non-institutional shareholders had a voter turnout of 29.3986%.
- · No invalid votes were recorded in any category.
16-08-2026
ICODEX PUBLISHING SOLUTIONS LIMITED announced that its shareholders have approved two special resolutions via postal ballot: (1) variation in the objects/terms of utilization of IPO proceeds and modification of the time limit for their use, and (2) ratification of deviation in utilization of IPO proceeds. The resolutions were passed with the requisite majority, as confirmed by the scrutinizer's report. This indicates that the company had deviated from the originally stated use of IPO funds and sought shareholder approval to legitimize the change.
- · The postal ballot notice was dated July 10, 2026.
- · Remote e-voting period: July 17, 2026 (9:00 AM IST) to August 14, 2026 (5:00 PM IST).
- · The scrutinizer submitted his report on August 14, 2026.
- · Both resolutions were passed as Special Resolutions.
- · The company's ISIN is INE111601014 and scrip code is 544483.
16-08-2026
Superior Finlease Limited published newspaper clippings of its un-audited standalone financial results for the quarter ended June 30, 2026, in The Financial Express (English) and The Jansatta (Hindi) on August 15, 2026, as required under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing is a routine compliance disclosure; no specific financial figures are legible in the provided text.
- · The newspaper clippings were published on August 15, 2026, in The Financial Express (English) and The Jansatta (Hindi).
- · The results are for the quarter ended June 30, 2026.
- · The filing is made under Regulation 47 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
16-08-2026
Natural Capsules Limited reported standalone revenue from operations of ₹4,302.07 Lakh for Q1 FY27 (June 2026), down 2.8% YoY from ₹4,424.29 Lakh in Q1 FY26, while standalone net profit surged 60.0% YoY to ₹403.63 Lakh from ₹252.30 Lakh. On a consolidated basis, revenue grew 7.8% YoY to ₹4,871.19 Lakh, but the company continued to report a consolidated net loss of ₹574.38 Lakh, albeit slightly narrower than the ₹558.05 Lakh loss in the same quarter last year. Sequentially, standalone revenue declined 15.3% from the March 2026 quarter, while consolidated revenue fell 16.7%.
- · Standalone other income rose 36.5% YoY to ₹230.84 Lakh (from ₹169.08 Lakh).
- · Standalone finance cost increased 6.1% YoY to ₹144.03 Lakh.
- · Standalone depreciation rose 5.5% YoY to ₹209.91 Lakh.
- · Consolidated finance cost surged 96.5% YoY to ₹497.35 Lakh (from ₹253.03 Lakh).
- · Consolidated depreciation increased 2.8% YoY to ₹433.09 Lakh.
- · Consolidated employee benefits expense rose 5.2% YoY to ₹523.64 Lakh.
- · Standalone paid-up equity share capital increased to ₹1,041.12 Lakh from ₹1,034.12 Lakh a year ago.
- · Consolidated net loss for the trailing twelve months (year ended Mar 2026) stood at ₹2,466.34 Lakh.
16-08-2026
IFGL Refractories Limited announced the promotion and appointment of Mr. Ashok Kumar Kedia (Vice President of Finance) and Mr. Frank Mitchell (Vice President of Manufacturing) as Co-Presidents of its material US subsidiary, Mono Ceramics Inc (MCI), effective August 16, 2026. This follows the cessation of Mr. Mukesh Harshadrai Rawal as President of MCI. The appointments reflect a leadership transition at the subsidiary level, with both executives having long tenures (28+ and 37+ years respectively) with the group.
- · Mr. Kedia holds B.Com (Hons), is an Associate Member of ICAI, ICSI, ICMAI, IMA(USA), and holds a CPA license from Montana.
- · Mr. Mitchell holds a High School Diploma and has completed college coursework.
- · The cessation of Mr. Rawal was previously intimated on April 22, 2026 and August 8, 2026.
16-08-2026
Rishabh Instruments reported Q1FY27 consolidated revenue of ₹1,983 Mn, up 4.2% YoY, and consolidated EBITDA of ₹333 Mn, up 17.3% YoY. The EEI segment drove growth with 34.0% YoY revenue increase and 24.8% adjusted EBITDA margins, while the HPDC segment saw revenue decline 41.2% YoY and remained at an operating loss. Consolidated PAT was nearly flat at ₹194 Mn, down 1.4% YoY.
- · Consolidated gross margin declined 140 bps YoY to 62.4% in Q1FY27.
- · Consolidated PAT margin declined 50 bps YoY to 9.8% in Q1FY27.
- · Standalone EBITDA margin declined 20 bps YoY to 22.9% in Q1FY27.
- · Standalone PAT margin declined 70 bps YoY to 15.3% in Q1FY27.
- · HPDC segment reported an adjusted EBITDA loss of ₹28 Mn in Q1FY27 vs. a profit of ₹77 Mn in Q1FY26.
- · HPDC segment gross margin was nearly flat at 67.2% vs. 67.3% YoY.
- · EEI segment gross margin declined 50 bps YoY to 61.0%.
- · Consolidated other income declined from ₹43 Mn to ₹36 Mn YoY.
- · Consolidated finance cost decreased from ₹12 Mn to ₹9 Mn YoY.
- · Geographically, Asia contributed 62.5% of consolidated revenue in Q1FY27, Europe 26.2%, and Others 11.3%.
16-08-2026
Vishvprabha Ventures Limited published its consolidated and standalone unaudited financial results for the quarter ended June 30, 2026, in newspapers (Financial Express and Pratahkal) as required under SEBI Listing Regulations. The filing is a routine disclosure of the newspaper advertisement and does not contain the actual financial figures or any commentary on performance.
- · The newspaper publication was made in Financial Express (English) and Pratahkal (Marathi).
- · The filing is dated August 16, 2026, and the results are for the quarter ended June 30, 2026.
- · The company's scrip code is 512064 on BSE.
- · The filing is made under Regulations 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
16-08-2026
Exato Technologies has announced an earnings call for Q1FY27 on August 19, 2026, following the release of its unaudited financial results for the quarter ended June 30, 2026. The call is scheduled for 4:00 PM IST and is open to investors and analysts. No financial results or performance metrics are provided in this filing.
- · The earnings call is scheduled for Wednesday, August 19, 2026 at 04:00 P.M. (IST).
- · Registration for the call requires using the Diamond Pass web link provided in the attached invite.
- · The schedule is also being uploaded on the company's website https://www.exato.ai/ under the Investor section.
- · The filing is made under Regulation 30 and Regulation 46(2)(o) of SEBI (LODR) Regulations, 2015.
16-08-2026
WSFx Global Pay Limited reported strong YoY growth for Q1 FY27, with gross turnover rising 36.24% to ₹1,491 Cr and revenue from operations up 27.57% to ₹23.23 Cr. Profit before tax surged 255.63% to ₹0.583 Cr, and PAT increased 83.82% to ₹0.301 Cr, demonstrating operating leverage. However, the retail segment declined 13.02% YoY, and the company noted cyclical headwinds from geopolitical volatility, FX swings, and US visa policy uncertainty.
- · Student segment grew 46.83% YoY, the single largest driver of the quarter.
- · Corporate segment grew 13.75% YoY with 67 new corporate clients onboarded.
- · Retail segment declined 13.02% YoY due to market conditions.
- · 47 new B2B partnerships were added in Q1.
- · 3 new branches opened in Pune (Hinjewadi), Gurugram, and Bangalore (Whitefield).
- · AD-II outward remittance grew 48.69% YoY.
- · Gross revenue CAGR (since FY21) is 39.72%; SGA expenses CAGR is 19.21%.
- · Remittance GTO CAGR (since FY21) is 48.48%; Forex Card GTO CAGR is 90.96%.
- · Corporate segment GTO CAGR (since FY21) is 65.89%; Retail segment GTO CAGR is 38.07%.
- · Cyclical headwinds noted: geopolitical volatility, INR/USD swings, US visa policy uncertainty, and softened retail forex demand.
16-08-2026
HDFC Bank has informed the stock exchanges of a Debt Investor Roadshow scheduled for August 19, 2026, to be held virtually. The meeting is part of the bank's ongoing engagement with institutional investors and debt investors. No financial results or material business developments were disclosed in this filing.
- · The roadshow is scheduled for August 19, 2026.
- · The mode of the meeting is virtual.
- · The filing is made under Regulation 30 of SEBI (LODR) Regulations, 2015.
- · The schedule may change due to exigencies; any revision will be communicated to stock exchanges.
16-08-2026
Embassy Developments Limited (formerly Equinox India Developments Limited) has convened its 20th Annual General Meeting to be held on September 8, 2026, via video conferencing. The agenda includes adoption of audited financial statements, re-appointment of Chairman Jitendra Virwani, approval of cost auditor remuneration, revision of CFO Rajesh Kaimal's remuneration, appointment of Neel Virwani as Chief Business Officer, and a preferential issue of warrants. The meeting will be conducted electronically, with remote e-voting from September 5 to 7, 2026.
- · AGM date: September 8, 2026, at 11:30 A.M. IST via VC/OAVM.
- · Cut-off date for voting rights: September 1, 2026.
- · Remote e-voting window: September 5-7, 2026.
- · Preferential issue of warrants is on the agenda as a special resolution.
- · Revision in CFO remuneration effective from December 1, 2025.
- · Cost auditor remuneration: ₹3.00 Lakh plus taxes and out-of-pocket expenses.
- · Annual Report for FY 2025-26 is available on company website.
16-08-2026
Apollo Micro Systems Limited has received final comments from SEBI on the draft letter of offer for its open offer to acquire 26% of the equity shares of Premier Explosives Limited (PEL) from public shareholders. The company will proceed with the next steps as recommended by SEBI and as required under the SEBI SAST regulations. This update follows the initial announcement made on July 9, 2026.
- · SEBI's final comments were conveyed via letter dated August 14, 2026, and received by the company on August 16, 2026.
- · The open offer is being made under the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
- · The company had previously announced the open offer on July 9, 2026.
16-08-2026
Embassy Developments Limited has convened its 20th Annual General Meeting (AGM) to be held on September 8, 2026, via video conferencing. The agenda includes adoption of audited financial statements for FY2025-26, re-appointment of Chairman Jitendra Virwani, approval of cost auditor remuneration of ₹3.00 Lakh, revision in CFO Rajesh Kaimal's remuneration, appointment of Neel Virwani as Chief Business Officer, and a preferential issue of warrants. No financial performance figures or period-over-period comparisons are disclosed in this filing.
- · AGM will be held on Tuesday, September 8, 2026 at 11:30 AM IST via VC/OAVM.
- · Remote e-voting period: September 5, 2026 (10:00 AM) to September 7, 2026 (5:00 PM).
- · Cut-off date for voting rights: September 1, 2026.
- · Speaker registration and queries: September 2 to September 4, 2026.
- · Agenda includes a special resolution for preferential issue of warrants.
- · Mr. Neel Virwani, a promoter group member and relative of Jitendra Virwani and Aditya Virwani, is proposed to be appointed as Chief Business Officer (related party transaction).
- · Revision in CFO Rajesh Kaimal's remuneration is effective from December 1, 2025, and requires a special resolution.
- · Cost auditor remuneration fixed at ₹3.00 Lakh plus taxes and out-of-pocket expenses.
16-08-2026
Natco Pharma has informed the stock exchanges that its officials will participate in an investor meeting organized by Nuvama Wealth Management and ICICI Securities from August 19 to August 21, 2026, in Mumbai. The meeting is an in-person group meeting, and the company states that no unpublished price sensitive information will be discussed.
- · Meeting dates: August 19-21, 2026, from 9:00 AM to 5:00 PM.
- · Meeting type: In-person group meeting.
- · Location: Mumbai, Maharashtra.
16-08-2026
Digjam Ltd held an NCLT-convened meeting of equity shareholders on August 16, 2026, to seek approval for a Scheme of Arrangement involving Reid & Taylor International Private Limited (RTIL) as the demerged company and Digjam as the resulting company. The meeting was conducted via video conference with a quorum present, and shareholder queries were addressed. The e-voting results are to be announced by August 18, 2026.
- · The meeting was convened pursuant to NCLT Chennai Bench order dated June 19, 2026.
- · The cut-off date for dispatch of meeting notices was July 3, 2026.
- · The meeting lasted from 11:00 AM to 11:20 AM IST, with e-voting open for an additional 30 minutes.
- · NSDL provided facilities for remote e-voting, video conferencing participation, and e-voting during the meeting.
- · The Scheme of Arrangement involves Reid & Taylor International Private Limited as the demerged company and Digjam Limited as the resulting company.
16-08-2026
Virat Industries Ltd has informed BSE that its management will host an investor meeting call on August 21, 2026, to discuss a proposal for acquiring a stake in Brahm Lifestyle Products Private Limited. The company stated that no unpublished price sensitive information (UPSI) is intended to be discussed during the call.
- · The investor meeting call is scheduled for Friday, 21st August 2026 at 17:00 hrs India Time.
- · The call is a group call to discuss the proposal for acquisition of stake in Brahm Lifestyle Products Private Limited.
- · The meeting link, access credentials, and presentation will be shared separately.
Get daily alerts with 9 investment signals, 8 risk alerts, 8 opportunities and full AI analysis of all 22 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India Stock Market Daily Regulatory Digest
August 14, 2026
India Stock Market Daily Regulatory Digest — August 14, 2026
August 13, 2026
India Stock Market Daily Regulatory Digest — August 13, 2026
August 11, 2026
India Stock Market Daily Regulatory Digest — August 11, 2026
August 10, 2026
India Stock Market Daily Regulatory Digest — August 10, 2026
🇮🇳 More from India
View all →August 16, 2026
India Pre-Market Regulatory Roundup — August 16, 2026
India Pre-Market Regulatory Roundup
August 16, 2026
India Merger Acquisition MCA Regulatory Filings — August 16, 2026
India Merger Acquisition MCA Regulatory Filings
August 16, 2026
BSE Sensex 30 Stocks Regulatory Filings — August 16, 2026
BSE Sensex 30 Stocks Regulatory Filings
August 16, 2026
India Sector Consolidation Regulatory Filings — August 16, 2026
India Sector Consolidation Regulatory Filings